Uriage Xemose SOS Anti-Itch Moisturising Mist 200ml

Uriage Xemose SOS Anti-Itch Moisturising Mist 200ml

Marsoni

M251S

$46.48

Get it in 3 business days with 1 day shipping. Friday, May 29

Uriage Xemose SOS Anti-Itch Moisturising Mist 200mlAnti itch mist. Provides instant relief from itching and soothes skin. Features All the Xmose efficacy in a light and fresh SOS Mist. Anti itch Anti dryness Anti recurrence Triple skin barrier reinforcement. Soothes in Less Than 60 Seconds Instant anti itch high efficacy Practical and playful use. Nourishes Intensely 10% Shea Butter + Illipe oil for intense nutrition. Long lasting Comfort 24H anti recurrence action Long lasting comfort: comfortable

Easy Shipping

Quick Dispatch:

Your Uriage Xemose SOS Anti-Itch Moisturising Mist 200ml orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Uriage Xemose SOS Anti-Itch Moisturising Mist 200ml ships.

Need Help?
Questions about Uriage Xemose SOS Anti-Itch Moisturising Mist 200ml, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Uriage Xemose SOS Anti-Itch Moisturising Mist 200ml in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

This soap worked wonders for my psoriasis. It was very gentle on my skin. The bars lasted a long time which I feel like made it worth the money. The ingredients being all natural is also a plus for this product. While it didn't make my psoriasis flaw-up go away it did help with the itchiness of the areas. And it just soothe my skin.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on May 7, 2026